Please wait a minute...
医药导报  2019, Vol. 38 Issue (6): 687-692    DOI: 10.3870/j.issn.1004-0781.2019.06.001
  本期目录 | 过刊浏览 | 高级检索 |
国际药理学专家谈医药科技创新及对学术交流的思考*
赵颖1,2(),穆鑫1,2,周文霞2,3,张永祥2,3(),杜冠华1,2()
1.中国医学科学院北京协和医学院药物研究所,北京 100050
2.中国药理学会,北京 100050
3.军事科学院军事医学研究院毒物药物研究所,北京 100850
International Interview with Pharmacologists on Medical Scientific and Technological Innovation and Suggestions on Scientific Communication
Ying ZHAO1,2(),Xin MU1,2,Wenxia ZHOU2,3,Yongxiang ZHANG2,3(),Guanhua DU1,2()
1.Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
2.Chinese Pharmacological Society,Beijing 100050,China
3.Institute of Pharmacology and Toxicology,Academy of Military Medical Sciences, Beijing 100850,China
全文: PDF(1193 KB)   HTML
输出: BibTeX | EndNote (RIS)      
摘要 

该文对国内外8位药理学专业专家进行了深入访谈,探讨:①学术交流对于科技创新(如药理学理论与技术创新、新药研发等)和人才培养的作用;②整合与利用国际专家和专业资源、促进我国科技创新、人才培养以及提升我国在国际组织的影响力和话语权等方面的建议。通过访谈,总结先前国际交流成功的经验及存在的问题,给出今后发展的建议,为进一步提升中国药理学会的国际学术交流水平,进一步为发挥国际学术交流在国家科技创新体系中的作用提供参考。

服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
赵颖
穆鑫
周文霞
张永祥
杜冠华
关键词 药理学访谈学术交流科技创新人才培养    
Abstract

To investigate ① the role of international communication on scientific and technological innovation issues such as new drug research and development,pharmacological theory and technological innovation,education,personnel training; ② comments of the patterns to enhance communications with international experts and to use professional resources,thus to promote domestic scientific and technological innovation,to enhance personal training,and to strengthen the international influence of the society,eight pharmacologists from either China or abroad were interviewed. The successful experiences and existing problems were summarized from the interviews. The suggestions of future development were proposed to improve the level of international scientific communication of Chinese Pharmacological Society,and thus provide further reference for displaying functions of international scientific communication on the national system of scientific and technological innovation.

Key wordsPharmacology    Interview    Scientific communication    Scientific and technological innovation    Personal training
收稿日期: 2019-03-18      出版日期: 2019-06-11
基金资助:*中国科协九大代表2018年调研课题专项
引用本文:   
赵颖,穆鑫,周文霞,张永祥,杜冠华. 国际药理学专家谈医药科技创新及对学术交流的思考*[J]. 医药导报, 2019, 38(6): 687-692.
Ying ZHAO,Xin MU,Wenxia ZHOU,Yongxiang ZHANG,Guanhua DU. International Interview with Pharmacologists on Medical Scientific and Technological Innovation and Suggestions on Scientific Communication. Herald of Medicine, 2019, 38(6): 687-692.
链接本文:  
http://www.yydbzz.com/CN/10.3870/j.issn.1004-0781.2019.06.001      或      http://www.yydbzz.com/CN/Y2019/V38/I6/687
[1] 郭巧生,王长林.我国药用植物栽培历史概况与展望[J].中国中药杂志,2015,40(17):3391-3394.
[2] HAMEDI A,ZARSHENAS M M,SOHRABPOUR M,et al.Herbal medicinal oils in traditional Persian medicine[J].Pharm Biol,2013,51(9):1208-1218.
doi: 10.3109/13880209.2013.777462
[3] RUPANI R,CHAVEZ A.Medicinal plants with traditional use:Ethnobotany in the Indian subcontinent[J]. Clin Dermatol,2018,36(3):306-309.
doi: 10.1016/j.clindermatol.2018.03.005
[4] DESBOROUGH M J R,KEELING D M. The aspirin story-from willow to wonder drug[J]. Br J Haematol,2017,177(5):674-683.
doi: 10.1111/bjh.2017.177.issue-5
[5] KHAN M O,DEIMLING M J,PHILIP A.Medicinal chemistry and the pharmacy curriculum[J].Am J Pharm Educ,2011,75(8):161.
doi: 10.5688/ajpe758161 pmid: 3220342
[6] Nobel Media AB 2019. The Nobel Prize in Physiology or Medicine 2018[A/OL]. (2016-10-01)[2019-03-14]. https://www.nobelprize.org/prizes/medicine/2018/summary/.
[7] MILLAN M J,GOODWIN G M,MEYER-lINDENBERG A,et al. Learning from the past and looking to the future:Emerging perspectives for improving the treatment of psychiatric disorders[J].Eur Neuropsychopharmacol,2015,25(5):599-656.
doi: 10.1016/j.euroneuro.2015.01.016 pmid: 25836356
[8] PANKEVICH D E,ALTEVOGT B M,DUNLOP J,et al.Improving and accelerating drug development for nervous system disorders[J]. Neuron,2014,84(3):546-553.
doi: 10.1016/j.neuron.2014.10.007
[9] ESCH E W,BAHINSKI A,HUH D.Organs-on-chips at the frontiers of drug discovery[J].Nat Rev Drug Discov,2015,14(4):248-260.
[10] BORENSTEIN J T.Organs-on-chips:how microsystems technology can transform the drug development process[J].IEE Pulse,2016,7(2):22-26.
doi: 10.1109/MPUL.2015.2513722
[11] TAKAHASH T.Organoids for drug discovery and persona-lized medicine[J].Ann Rev Pharmacol Toxicol,2019,59:447-462.
doi: 10.1146/annurev-pharmtox-010818-021108
[12] ROSSI G,MANFRIN A,LUTOLF M P.Progress and potential in organoid research[J]. Nat Rev Genetics,2018,19(11):671-687.
doi: 10.1038/s41576-018-0051-9
[13] CHEN K G,MALLON B S,PARK K,et al.Pluripotent stem cell platforms for drug discovery[J]. Trends Mol Med,2018,24(9):805-820.
doi: 10.1016/j.molmed.2018.06.009
[14] ZHANG L,TAN J,HAN D,et al.From machine learning to deep learning:progress in machine intelligence for rational drug discovery[J].Drug Discov Today,2017,22(11):1680-1685.
doi: 10.1016/j.drudis.2017.08.010
[15] CAMACHO D M,COLLINS K M,POWERS R K,et al.Next-generation machine learning for biological networks[J]. Cell,2018,173(7):1581-1592.
doi: 10.1016/j.cell.2018.05.015
[16] Nobel Media AB 2019. Charles K.Kao-Facts[A/OL].(2019-12-08)[2019-03-14].https://www.nobelprize.org/prizes/physics/2009/kao/facts/.
[17] Nobel Media AB 2019. Daniel C.Tsui-Facts[A/OL].(1998-12-08)[2019-03-14].https://www.nobelprize.org/prizes/physics/1998/tsui/facts/.
[18] Nobel Media AB 2019. Chen Ning Yang-Facts[A/OL]. (1957-12-11)[2019-03-14].https://www.nobelprize.org/prizes/physics/1957/yang/facts/.
[19] Nobel Media AB 2019.Tsung-Dao Lee-Facts[A/OL]. (1957-12-11)[2019-03-14].https://www.nobelprize.org/prizes/physics/1957/lee/facts/.
[20] Nobel Media AB 2019.Enrico Fermi-Facts[A/OL]. (1938-12-12)[2019-03-14].https://www.nobelprize.org/prizes/physics/1938/fermi/facts/.
[21] 刘干中. 中国药理学会成立30周年祝词[J]. 中国药理学与毒理学杂志,2015,29(5):678.
doi: 10.3867/j.issn.1000-3002.2015.05.006
[22] FACCENDA E,MAXWELL S,SZAREK J L.The IUPHAR pharmacology education project[J]. Clin Pharmacol Ther,2019,105(1):45-48.
doi: 10.1002/cpt.1278
[23] BARRETT J E,MCGONIGLE P,CLARK J E.Graduate education in pharmacology:addressing the need for specialized training for pharmaceutical and biotechnology careers[J].Pharmacol Res,2016,113(Pt A):327-331.
doi: 10.1016/j.phrs.2016.08.030
[1] 周荣荣,李培硕,关伟,王丽萍,李彦文,李志勇. 基于整合药理学平台天麻治疗头痛的作用机制*[J]. 医药导报, 2019, 38(6): 706-710.
[2] 杨相立,韦升利,王林,董林毅,赵振营,刘吉祥. 喉痹中药组方规律探索及整合药理学分子机制*[J]. 医药导报, 2019, 38(4): 419-424.
[3] 慕桂娟,陆景坤,王跃武,孙雨辉,那生桑,孙宇鑫,胡玉崇. 基于网络药理学探讨朱日亨滴丸治疗冠心病的分子机制*[J]. 医药导报, 2019, 38(4): 430-434.
[4] 石垚,张巧艳,青梅,辛海量. 网络药理学方法在中药研究领域的应用*[J]. 医药导报, 2018, 37(增刊): 38-41.
[5] 陈璟,吕志阳,顾雪梅,何立巍,单鑫,涂清波,钱洁,聂锐. 药学类专业校企合作实践教学体系的构建——以南京中医药大学翰林学院为例*[J]. 医药导报, 2018, 37(8): 1023-1025.
[6] 赵颖,穆鑫,杜冠华. 药理学与药学服务[J]. 医药导报, 2015, 34(9): 1127-1130.
[7] 余早勤;张程亮;王友群;刘东 . 疼痛的昼夜节律与镇痛药物治疗[J]. , 2014, 33(6): 771-774.
[8] 周宏萍;白秋江;郑敏. HER2阳性晚期乳腺癌治疗新药——曲妥珠单抗共轭复合物[J]. , 2014, 33(1): 79-81.
[9] 韩梅;葛明. 治疗多发性骨髓瘤新药——卡非佐米[J]. , 2013, 32(9): 1200-1202.
[10] 何国珍;岑妍慧;杨美春;黎敏;李莉;吴诚 . 班氏促卵助孕煎剂含药血清对体外培养人卵巢颗粒细胞增殖的影响[J]. , 2013, 32(4): 424-427.
[11] 李岩峰;白秋江;郑敏. 治疗症状性黄斑粘连新药ocriplasmin[J]. , 2013, 32(12): 1622-1623.
[12] 丁媛媛;邱麟;曾明;许茜;许景峰 . 肉桂油抗柯萨奇病毒B3的血清药理学研究[J]. , 2012, 31(7): 870-873.
[13] 杨凡;赵钢涛;丁媛媛;许景峰. 基因多态性对华法林的影响[J]. , 2012, 31(6): 771-774.
[14] 张浩;昝金行;龙伟;刘培勋. 基于分子对接方法的中药抗炎机制研究*[J]. , 2012, 31(12): 1542-1546.
[15] 马立娟;黄贞龙;李力;李宗锴 . 抗肺纤维化药物的研究进展[J]. , 2012, 31(1): 57-59.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   

通信地址:武汉市蔡甸区中法生态城同济医院专家社区C栋平层《医药导报》编辑部,邮政编码:430199
鄂ICP备07004419号
版权所有:《医药导报》编辑部
网址:www.yydb.cn;www.yydbzz.com
电话:027-69378382,69378383 电子邮箱: yydbzz@163.com
技术支持:北京玛格泰克科技发展有限公司 鄂ICP备09001709号-11